|
Name: N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide
Type: Synthetic cannabinoid
AKA: AB-CHMINACA, synthetic cannabinoids
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
This synthetic cannabinoid was developed in the 2000s as part of a broader effort to create compounds with effects similar to THC. It is known for its high potency and has been studied for its interaction with cannabinoid receptors. Synthetic cannabinoids like this have been used in research and are controlled due to their potential for abuse and health risks.
|
|
V. Legal Information
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, a synthetic cannabinoid, is often regulated under analog laws due to its potential for abuse. In the US, it could be controlled under the Federal Analog Act if similar to other controlled substances. Globally, its legal status is restrictive, with many countries implementing controls on synthetic cannabinoids to manage abuse risks.
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide is a synthetic cannabinoid known for its potent psychoactive effects. As an upper, it can cause intense euphoria and altered perception. Short-term effects include increased heart rate and potential anxiety, while long-term use can lead to severe mental health issues. Overdose risks involve acute psychosis and cardiovascular problems. Safe use is challenging due to potency variability. Recent research highlights its dangerous effects and the need for careful regulation.  |
|
VII. Psychological Effects
N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, a synthetic cannabinoid, binds to cannabinoid receptors, causing mood alteration and cognitive effects. Immediate effects include euphoria and relaxation, while long-term use may result in anxiety, cognitive impairments, and severe mental health issues. Research focuses on its potency, safety, and psychological impact.
 |
|
VIII. Culture
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide is a synthetic cannabinoid with psychoactive properties. Its cultural significance is tied to the broader issues of synthetic cannabinoids, including unpredictability and health risks. The substance highlights the challenges of synthetic drug regulation and the need for effective public health strategies. Its role in the cultural narrative is one of caution and awareness, reflecting the ongoing concerns about synthetic cannabinoid use and its impact on society.
 |